Sarcoma  >>  Nailike (olverembatinib)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Nailike (olverembatinib) / Ascentage Pharma, Takeda
SJ-0003, NCT03594422: A Study of HQP1351 in Patients With GIST or Other Solid Tumors

Recruiting
1
100
RoW
HQP1351
Ascentage Pharma Group Inc., HealthQuest Pharma Inc.
Gastrointestinal Stromal Tumor (GIST), Solid Tumor, Adult
12/24
12/26

Download Options